Gender- and age-related treatment compliance in patients with osteoporosis in Germany

References

• Facts and StatisticsInternational Osteoporosis Foundation Available from: https://www.iofbonehealth.org/facts-statisticsAccessed July 18, 2016
   Google Scholar
• HöerASeidlitzCGotheHInfluence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosisPatient Prefer Adherence20093253019936142
   PubMed Web of Science ®Google Scholar
• BlackDMBauerDCSchwartzAVCummingsSRRosenCJContinuing bisphosphonate treatment for osteoporosis – for whom and for how long?N Engl J Med2012366222051205322571169
   PubMed Web of Science ®Google Scholar
• HadjiPPapaioannouNGielenEPersistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional studyOsteoporos Int201526102479248926018090
   PubMed Web of Science ®Google Scholar
• HadjiPKleinSHäusslerBThe bone evaluation study (BEST): patient care and persistence to treatment of osteoporosis in GermanyInt J Clin Pharmacol Ther2013511186887224040854
   PubMed Web of Science ®Google Scholar
• DeziiCMPersistence with drug therapy: a practical approach using administrative claims dataManag Care20011024245
   Google Scholar
• AndradeSEKahlerKHFrechFChanKAMethods for evaluation of medication adherence and persistence using automated databasesPharmacoepidemiol Drug Saf2006158565574 discussion 575–57716514590
   PubMed Web of Science ®Google Scholar
• HadjiPImproving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapyCrit Rev Oncol Hematol201073215616619299162
   PubMed Web of Science ®Google Scholar
• ZillerVKostevKKyvernitakisIBoeckhoffJHadjiPPersistence and compliance of medications used in the treatment of osteoporosis – analysis using a large scale, representative, longitudinal German databaseInt J Clin Pharmacol Ther201250531532222541835
   PubMed Web of Science ®Google Scholar
• HadjiPClausVZillerVIntorciaMKostevKSteinleTGRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonatesOsteoporos Int201223122323121308365
   PubMed Web of Science ®Google Scholar
• LakatosPTakácsIMartonIA retrospective longitudinal database study of persistence and compliance with treatment of osteoporosis in HungaryCalcif Tissue Int201698321522526686694
   PubMed Web of Science ®Google Scholar
• BecherHKostevKSchröder-BernhardiDValidity and representativeness of the “Disease Analyzer” patient database for use in pharmacoepidemiological and pharmacoeconomic studiesInt J Clin Pharmacol Ther2009471061762619825325
   PubMed Web of Science ®Google Scholar
• JacobLDreherMKostevKHadjiPIncreased treatment persistence and its determinants in women with osteoporosis with prior fracture compared to those without fractureOsteoporos Int201627396396926519418
   PubMed Web of Science ®Google Scholar
• DrosselmeyerJRappMAHadjiPKostevKDepression risk in female patients with osteoporosis in primary care practices in GermanyOsteoporos Int20162792739274427026332
   PubMed Web of Science ®Google Scholar
• JacobLHadjiPKostevKThe use of proton pump inhibitors is positively associated with osteoporosis in postmenopausal women in GermanyClimacteric201619547848127352629
   PubMed Web of Science ®Google Scholar
• HuasDDebiaisFBlotmanFCompliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatmentBMC Womens Health2010102620727140
   PubMed Web of Science ®Google Scholar
• BrodMStewartALSandsLWaltonPConceptualization and measurement of quality of life in dementia: the dementia quality of life instrument (DQoL)Gerontologist1999391253510028768
   PubMed Web of Science ®Google Scholar
• KishimotoHMaeharaMCompliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISAArch Osteoporos20151023126297076
   PubMed Web of Science ®Google Scholar
• GoldDTTrinhHSafiWWeekly versus monthly drug regimens: 1-year compliance and persistence with bisphosphonate therapyCurr Med Res Opin20092581831183919530982
   PubMed Web of Science ®Google Scholar
• CarrAJThompsonPWCooperCFactors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional surveyOsteoporos Int200617111638164416896510
   PubMed Web of Science ®Google Scholar
• KertesJDushenatMVestermanJLLembergerJBregmanJFriedmanNFactors contributing to compliance with osteoporosis medicationIsr Med Assoc J200810320721318494234
   PubMed Web of Science ®Google Scholar
• CaroJJIshakKJHuybrechtsKFRaggioGNaujoksCThe impact of compliance with osteoporosis therapy on fracture rates in actual practiceOsteoporos Int200415121003100815167989
   PubMed Web of Science ®Google Scholar
• SirisESSelbyPLSaagKGBorgströmFHeringsRMSilvermanSLImpact of osteoporosis treatment adherence on fracture rates in North America and EuropeAm J Med20091222 SupplS3S13
   PubMed Web of Science ®Google Scholar
• KennelKADrakeMTAdverse effects of bisphosphonates: implications for osteoporosis managementMayo Clin Proc200984763263719567717
   PubMed Web of Science ®Google Scholar
• SegalETamirAIsh-ShalomSCompliance of osteoporotic patients with different treatment regimensIsr Med Assoc J200351285986214689753
   PubMed Web of Science ®Google Scholar
• SolomonDHAvornJKatzJNCompliance with osteoporosis medicationsArch Intern Med2005165202414241916287772
   PubMed Web of Science ®Google Scholar
• PapaioannouDAKennedyCCDolovichLLauEAdachiJDPatient adherence to osteoporosis medications: problems, consequences and management strategiesDrugs Aging2007241375517233546
   PubMed Web of Science ®Google Scholar
• ThorsteinssonALVestergaardPEikenPCompliance and persistence with treatment with parathyroid hormone for osteoporosis. A Danish national register-based cohort studyArch Osteoporos2015103526427867
   PubMed Web of Science ®Google Scholar
• BabwahFBakshSBlakeLThe role of gender in compliance and attendance at an outpatient clinic for type 2 diabetes mellitus in TrinidadRev Panam Salud Pública2006192798416551381
   PubMed Web of Science ®Google Scholar
• JacobLHadjiPKostevKAge-related differences in persistence with bisphosphonates in women with metastatic breast cancerJ Bone Oncol201652636627335773
   PubMed Web of Science ®Google Scholar
• CalabriaSCinconzeERossiniMAdherence to alendronic or risedronic acid treatment, combined or not to calcium and vitamin D, and related determinants in Italian patients with osteoporosisPatient Prefer Adherence20161052353027143860
   PubMedGoogle Scholar